Benzinga | Feb 26, 2021 08:42AM EST

Credit Suisse Maintains Outperform on Teladoc Health, Raises Price Target to $300

Credit Suisse analyst Jailendra Singh maintains Teladoc Health (NYSE:TDOC) with a Outperform and raises the price target from $296 to $300.